Short description
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Description
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Founded on
January 1, 2009
Exited on
May 23, 2019
Went public on
May 23, 2019
Stock symbol
BCYC
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$7890 - 12340
Sign in for full access
Investors
Nopepepe, Nopepepe, No Way, Noaccess, Noaccessforu, Absolutely Noaccess, Nopepepe, Nopepepe, Uh Ohhhh, Uh Ohhhh, Absolutely Noaccess, Blurry Noaccess, Cannot Access, Cannot Access, Noaccess, Noaccess, Noaccess, Blurry Noaccess, Blurry Noaccess, Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Christian Heinis, Gregory Winter